inflammation

lion roaring
Biotech

Gilead roars into JPM25 with $250M upfront deal for Leo

Gilead has penned a major $1.7 billion deal with dermatology specialist Leo Pharma right before the J.P. Morgan Healthcare Conference begins.
Ben Adams Jan 11, 2025 5:30pm
reshuffle pipeline target reorganize shift change

Celldex drops phase 1 tumor bispecific to focus on inflammation

Nov 7, 2024 7:25am
pay deal hand over cash licensing transaction money

Ocean Biomedical pens $32M pact for Polish YKL-40 inhibitors

Oct 15, 2024 10:05am
GSK

GSK blockbuster hope depemokimab shrinks polyps in ph. 3 trials

Oct 14, 2024 4:51am
A patient receives hemodialysis

Invizius completes first-in-human ‘angry blood’ dialysis study

Jun 13, 2024 12:06pm
craft scissors glue paper glue stick

Takeda gets crafty with molecular glue deal worth $1.2B biobucks

May 23, 2024 5:30am